Substance / Medication

Dexamphetamine sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effectiveness and safety of dexamphetamine sulfate (Attentin) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study.
Uebel-von Sandersleben Henrik, Dangel Oliver, Fischer Roland et al. · Scand J Child Adolesc Psychiatr Psychol · 2021
PMID: 33928056OtherFull text (PMC)
CE assay for simultaneous determination of charged and neutral impurities in dexamphetamine sulfate using a dual CD system.
Wongwan Sudaporn, Sungthong Bunleu, Scriba Gerhard K E · Electrophoresis · 2010
PMID: 20358547Other
Impurity profiling of dexamphetamine sulfate by cyclodextrin-modified microemulsion electrokinetic chromatography.
Wongwan Sudaporn, Scriba Gerhard K E · Electrophoresis · 2010
PMID: 20690151Other
Profiling of levoamphetamine and related substances in dexamphetamine sulfate by capillary electrophoresis.
Kokiashvili Nino G, Wongwan Sudaporn, Landgraf Carina et al. · J Pharm Biomed Anal · 2009
PMID: 19574012Other
Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients.
Herbrink Maikel, Nuijten Masha, Nuijen Bastiaan et al. · J Clin Psychopharmacol · 2018
PMID: 29620701Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dexamfetamine sulfate (substance)
SNOMED CT
45207006
UMLS CUI
C0011810

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.